RXRX, ABCL, EXAI, SDGR all are using AI for drug discovery. It seems impossible to tell which companies will win. It seems like they have a ton of potential, because if AI is good at anything, it is large data tasks like this. I have stayed away though because I can’t tell who the winners will be.
